» Articles » PMID: 2591428

Role of Natural Killer Cells in Bladder Tumor

Overview
Journal Eur Urol
Specialty Urology
Date 1989 Jan 1
PMID 2591428
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The role of natural killer (NK) cells in bladder tumors was assessed from the aspect of local and systemic immune responses. The NK cell activity was measured in a 4-hour 51Cr-release assay. The NK activity in patients with bladder tumor was lower, though not significantly, than that in normal individuals. In patients with bladder tumor, the NK activity was significantly lower in invasive tumors and lymph node metastases. Moreover, the NK activity was lower in those who died (n = 4) than it was in survivors (n = 21). In an in vitro experiment, OK432 significantly augmented the NK activity in peripheral blood lymphocytes (PBL), however, this augmentation was not always OK432 dose-dependent. The augmented NK activity induced by OK432 occurred even in patients with invasive tumors. On the other hand, the spontaneous NK activity in tissue-infiltrating lymphocytes (TIL) and lymph node lymphocytes (LNL) was significantly lower than that in PBL. In these three groups, the NK activity was significantly increased by OK432, this rate of increase was highest in TIL, followed by LNL and PBL. Further studies are required to elucidate the role of NK cells in bladder tumor, from the aspect of local and systemic immune responses.

Citing Articles

Exploring the Immunoresponse in Bladder Cancer Immunotherapy.

Ruiz-Lorente I, Gimeno L, Lopez-Abad A, Lopez Cubillana P, Fernandez Aparicio T, Asensio Egea L Cells. 2024; 13(23.

PMID: 39682686 PMC: 11640729. DOI: 10.3390/cells13231937.


German Society of Neurology guidelines for the diagnosis and treatment of cognitive impairment and affective disorders in people with Parkinson's disease: new spotlights on diagnostic procedures and non-pharmacological interventions.

Kalbe E, Folkerts A, Witt K, Buhmann C, Liepelt-Scarfone I J Neurol. 2024; 271(11):7330-7357.

PMID: 39120709 PMC: 11561078. DOI: 10.1007/s00415-024-12503-0.


A Novel Natural Killer Cell-related Gene Signature for Improving the Prediction of Prognosis and Immunotherapy Response in Bladder Cancer.

Ma X, Wei X, Yang G, Li S, Liu R Comb Chem High Throughput Screen. 2023; 27(8):1205-1221.

PMID: 37653625 DOI: 10.2174/1386207326666230831164358.


Bladder tumor ILC1s undergo Th17-like differentiation in human bladder cancer.

Mukherjee N, Ji N, Tan X, Lin C, Rios E, Chen C Cancer Med. 2021; 10(20):7101-7110.

PMID: 34496133 PMC: 8525153. DOI: 10.1002/cam4.4243.


Endoplasmic Reticulum Stress and Tumor Microenvironment in Bladder Cancer: The Missing Link.

Nie Z, Chen M, Wen X, Gao Y, Huang D, Cao H Front Cell Dev Biol. 2021; 9:683940.

PMID: 34136492 PMC: 8201605. DOI: 10.3389/fcell.2021.683940.